{"id":111,"date":"2026-10-17T15:17:46","date_gmt":"2026-10-17T07:17:46","guid":{"rendered":"https:\/\/aclpharma.net\/?p=111"},"modified":"2026-10-17T15:17:46","modified_gmt":"2026-10-17T07:17:46","slug":"%e3%80%8a%e9%98%bf%e5%87%a1%e8%be%be%e3%80%8b%ef%bc%9a%e5%8d%a1%e6%a2%85%e9%9a%86%e6%bd%98%e5%a4%9a%e6%8b%89%e6%98%9f%e7%90%83","status":"publish","type":"post","link":"https:\/\/aclpharma.net\/?p=111","title":{"rendered":"\u300a\u963f\u51e1\u8fbe\u300b\uff1a\u5361\u6885\u9686\u6f58\u591a\u62c9\u661f\u7403"},"content":{"rendered":"<h2>\u5f71\u7247\u6982\u51b5<\/h2>\n<p>\u300a\u963f\u51e1\u8fbe\u300b\u7531\u8a79\u59c6\u65af\u00b7\u5361\u6885\u9686\u6267\u5bfc\uff0c\u8428\u59c6\u00b7\u6c83\u8f9b\u987f\u3001\u4f50\u4f0a\u00b7\u7d22\u5c14\u8fbe\u5a1c\u4e3b\u6f14\uff0c2009\u5e74\u4e0a\u6620\u3002\u5f71\u7247\u8bb2\u8ff0\u4eba\u7c7b\u5728\u672a\u6765\u6b96\u6c11\u6f58\u591a\u62c9\u661f\u7403\uff0c\u5f00\u91c7\u4e00\u79cd\u7a00\u6709\u77ff\u4ea7\uff0c\u53cc\u817f\u762b\u75ea\u7684\u524d\u6d77\u519b\u9646\u6218\u961f\u5458\u6770\u514b\uff0c\u901a\u8fc7\u963f\u51e1\u8fbe\u8eab\u4f53\u4e0e\u7eb3\u7f8e\u65cf\u4eba\u4ea4\u5f80\uff0c\u6700\u7ec8\u9009\u62e9\u7ad9\u5728\u539f\u4f4f\u6c11\u4e00\u8fb9\u53cd\u6297\u4eba\u7c7b\u7684\u6545\u4e8b\u3002\u5b83\u4ee53D\u6280\u672f\uff0c\u91cd\u5199\u4e86\u7535\u5f71\u5de5\u4e1a\u3002<\/p>\n<ul>\n<li><strong>\u5bfc\u6f14<\/strong>\uff1a\u8a79\u59c6\u65af\u00b7\u5361\u6885\u9686<\/li>\n<li><strong>\u4e3b\u6f14<\/strong>\uff1a\u8428\u59c6\u00b7\u6c83\u8f9b\u987f\u9970\u6770\u514b\u3001\u4f50\u4f0a\u00b7\u7d22\u5c14\u8fbe\u5a1c\u9970\u5948\u8482\u8389<\/li>\n<li><strong>\u6280\u672f<\/strong>\uff1a3D\u3001\u52a8\u4f5c\u6355\u6349\u3001\u865a\u62df\u6444\u5f71<\/li>\n<li><strong>\u7eaa\u5f55<\/strong>\uff1a\u5168\u7403\u5f71\u53f2\u7968\u623f\u7b2c\u4e00<\/li>\n<\/ul>\n<h2>\u5267\u60c5\u8109\u7edc<\/h2>\n<p>2154\u5e74\uff0c\u4eba\u7c7b\u6765\u5230\u6f58\u591a\u62c9\u661f\u7403\u2014\u2014\u4e00\u9897\u6709\u7a7a\u6c14\u3001\u6709\u68ee\u6797\u3001\u6709\u667a\u6167\u751f\u7269\u7eb3\u7f8e\u65cf\u7684\u7c7b\u5730\u884c\u661f\u3002\u4eba\u7c7b\u60f3\u5f00\u91c7\u4e00\u79cd\u53eb&#8221;unobtanium&#8221;\u7684\u7a00\u6709\u77ff\u77f3\uff0c\u4f46\u7eb3\u7f8e\u65cf\u5723\u6811\u6b63\u597d\u957f\u5728\u77ff\u8109\u4e0a\u3002<\/p>\n<p>\u53cc\u817f\u762b\u75ea\u7684\u524d\u6d77\u519b\u9646\u6218\u961f\u5458\u6770\u514b\uff0c\u901a\u8fc7\u963f\u51e1\u8fbe\uff08\u7528\u4eba\u7c7b\u4e0e\u7eb3\u7f8e\u65cfDNA\u5408\u6210\u7684\u8eab\u4f53\uff09\u8fdb\u5165\u6f58\u591a\u62c9\u68ee\u6797\u3002\u4ed6\u9047\u5230\u4e86\u7eb3\u7f8e\u65cf\u516c\u4e3b\u5948\u8482\u8389\uff0c\u88ab\u5979\u5e26\u5165\u7eb3\u7f8e\u65cf\u90e8\u843d\u3002\u4ed6\u4e00\u8fb9\u5b66\u4e60\u7eb3\u7f8e\u65cf\u7684\u751f\u6d3b\u65b9\u5f0f\uff0c\u4e00\u8fb9\u4e3a\u4eba\u7c7b\u519b\u961f\u505a\u5367\u5e95\u3002\u6700\u7ec8\u4ed6\u9009\u62e9\u7ad9\u5728\u7eb3\u7f8e\u65cf\u4e00\u8fb9\uff0c\u5e26\u9886\u6f58\u591a\u62c9\u661f\u7403\u6240\u6709\u751f\u7269\uff0c\u53cd\u6297\u4eba\u7c7b\u91c7\u77ff\u516c\u53f8\u3002<\/p>\n<h2>\u770b\u70b9\u4e0e\u6df1\u5ea6<\/h2>\n<p>\u300a\u963f\u51e1\u8fbe\u300b\u6700\u5927\u7684\u9769\u547d\u662f<strong>\u5b83\u76843D\u6280\u672f<\/strong>\u3002\u5361\u6885\u9686\u7528\u4ed6\u81ea\u5df1\u7814\u53d1\u76843D\u6444\u5f71\u673a\u4e0e\u865a\u62df\u6444\u5f71\u7cfb\u7edf\uff0c\u628a\u6574\u4e2a\u6f58\u591a\u62c9\u661f\u7403\u62cd\u5f97\u50cf\u771f\u7684\u3002\u5b83\u4e0a\u6620\u540e\uff0c\u5168\u7403\u5f71\u9662\u7eb7\u7eb7\u6539\u90203D\u8bbe\u5907\u3002<\/p>\n<p>\u5b83\u7684\u6545\u4e8b\u5176\u5b9e\u5f88\u7b80\u5355\u2014\u2014\u4e0e\u300a\u98ce\u4e2d\u5947\u7f18\u300b\u300a\u4e0e\u72fc\u5171\u821e\u300b\u7c7b\u4f3c\u2014\u2014\u4f46\u5b83\u7684\u6280\u672f\u4e0e\u89c6\u89c9\uff0c\u8ba9\u7535\u5f71\u8fdb\u5165\u4e86\u65b0\u65f6\u4ee3\u3002<\/p>\n<h2>\u5e55\u540e\u82b1\u7d6e\u4e0e\u63a8\u8350<\/h2>\n<p>\u5f71\u7247\u5168\u7403\u7968\u623f28\u4ebf\u7f8e\u5143\uff0c\u662f\u5f71\u53f2\u7b2c\u4e00\uff08\u540e\u88ab\u300a\u590d\u4ec7\u8005\u8054\u76df4\u300b\u77ed\u6682\u8d85\u8fc7\uff0c\u91cd\u6620\u540e\u53c8\u56de\u5230\u7b2c\u4e00\uff09\u3002\u5361\u6885\u9686\u4e3a\u5b83\u7b49\u4e8610\u5e74\uff0c\u56e0\u4e3a\u4ed6\u8981\u7b49\u6280\u672f\u6210\u719f\u3002\u7eed\u96c6\u300a\u963f\u51e1\u8fbe\uff1a\u6c34\u4e4b\u9053\u300b2022\u5e74\u4e0a\u6620\u3002<\/p>\n<ul>\n<li>\u8c46\u74e3\u8bc4\u52068.8\u5206\uff0c\u7535\u5f71\u5de5\u4e1a\u9769\u547d\u4e4b\u4f5c<\/li>\n<li>\u5168\u7403\u5f71\u53f2\u7968\u623f\u7b2c\u4e00<\/li>\n<li>\u9002\u5408\u5728IMAX3D\u5f71\u9662\u89c2\u770b<\/li>\n<\/ul>\n<p>\u540c\u7c7b\u63a8\u8350\uff1a\u300a\u963f\u51e1\u8fbe\uff1a\u6c34\u4e4b\u9053\u300b\u300a\u661f\u9645\u8ff7\u822a\u300b\u300a\u94f6\u6cb3\u62a4\u536b\u961f\u300b\u3002<\/p>\n<h2>\u6280\u672f\u4e0e\u4e3b\u9898\u89e3\u8bfb<\/h2>\n<p>\u5361\u6885\u9686\u4e3a\u8fd9\u90e8\u7247\u7b49\u4e86\u5341\u51e0\u5e74\uff0c\u672c\u8d28\u4e0a\u662f\u5728\u7b493D\u6444\u5f71\u4e0e\u52a8\u4f5c\u6355\u6349\u6280\u672f\u6210\u719f\u3002\u4ed6\u4e0e\u56e2\u961f\u81ea\u7814\u4e86\u865a\u62df\u6444\u5f71\u7cfb\u7edf\uff1a\u6f14\u5458\u5728\u7247\u573a\u8868\u6f14\u65f6\uff0c\u5bfc\u6f14\u80fd\u5b9e\u65f6\u770b\u5230\u4ed6\u4eec\u53d8\u6210\u7eb3\u7f8e\u4eba\u3001\u7f6e\u8eab\u6f58\u591a\u62c9\u68ee\u6797\u7684\u6548\u679c\u3002\u8fd9\u79cd&#8221;\u6240\u89c1\u5373\u6240\u5f97&#8221;\u7684\u5de5\u4f5c\u6d41\uff0c\u540e\u6765\u88ab\u6574\u4e2a\u7535\u5f71\u5de5\u4e1a\u6cbf\u7528\u3002<\/p>\n<p>\u6545\u4e8b\u539f\u578b\u5e76\u4e0d\u65b0\u9c9c\uff0c\u51e0\u4e4e\u662f\u300a\u4e0e\u72fc\u5171\u821e\u300b\u300a\u98ce\u4e2d\u5947\u7f18\u300b\u7684\u661f\u9645\u7248\u3002\u4eba\u7c7b\u91c7\u77ff\u516c\u53f8\u4ee3\u8868\u6b96\u6c11\u6269\u5f20\uff0c\u7eb3\u7f8e\u65cf\u4ee3\u8868\u4e0e\u81ea\u7136\u5171\u751f\u3002\u5361\u6885\u9686\u628a\u8fd9\u5c42\u9690\u55bb\u5305\u88c5\u5728\u5947\u5e7b\u89c6\u89c9\u91cc\uff0c\u8ba9\u89c2\u4f17\u5728\u6b23\u8d4f\u5947\u89c2\u7684\u540c\u65f6\uff0c\u81ea\u7136\u5730\u7ad9\u5230\u4e86\u539f\u4f4f\u6c11\u4e00\u8fb9\u3002<\/p>\n<p>\u5b83\u5bf9\u9662\u7ebf\u7684\u5f71\u54cd\u8fdc\u8d85\u5f71\u7247\u672c\u8eab\u30022009\u5e74\u4e4b\u540e\uff0c\u5168\u7403\u5f71\u9662\u624e\u5806\u5347\u7ea73D\u8bbe\u5907\uff0c3D\u4e00\u5ea6\u6210\u4e3a\u5927\u7247\u6807\u914d\u3002\u6f58\u591a\u62c9&#8221;\u4e07\u7269\u6709\u7075\u3001\u901a\u8fc7\u795e\u7ecf\u8fab\u8fde\u63a5\u4e00\u5207\u751f\u547d&#8221;\u7684\u751f\u6001\u8bbe\u5b9a\uff0c\u4e5f\u4e3a\u7eed\u96c6\u300a\u963f\u51e1\u8fbe\uff1a\u6c34\u4e4b\u9053\u300b\u7684\u6d77\u6d0b\u4e16\u754c\u57cb\u4e0b\u4e86\u4f0f\u7b14\u3002<\/p>\n<p>\u5b83\u544a\u8bc9\u4f60\uff1a\u6280\u672f\u7684\u9769\u547d\uff0c\u5f80\u5f80\u6765\u81ea\u4e00\u4e2a\u4eba\u613f\u610f\u4e3a\u5b83\u7b49\u5341\u5e74\u7684\u504f\u6267\u3002<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u5f71\u7247\u6982\u51b5 \u300a\u963f\u51e1\u8fbe\u300b\u7531\u8a79\u59c6\u65af\u00b7\u5361\u6885\u9686\u6267\u5bfc\uff0c\u8428\u59c6\u00b7\u6c83\u8f9b\u987f\u3001\u4f50\u4f0a\u00b7\u7d22\u5c14\u8fbe\u5a1c\u4e3b\u6f14\uff0c2009\u5e74\u4e0a\u6620\u3002\u5f71\u7247\u8bb2\u8ff0\u4eba\u7c7b\u5728\u672a\u6765\u6b96\u6c11\u6f58\u591a\u62c9\u661f\u7403\uff0c\u5f00\u91c7\u4e00\u79cd\u7a00\u6709\u77ff\u4ea7\uff0c\u53cc\u817f\u762b\u75ea\u7684\u524d\u6d77\u519b\u9646\u6218\u961f\u5458\u6770\u514b\uff0c\u901a\u8fc7\u963f\u51e1\u8fbe\u8eab\u4f53\u4e0e\u7eb3\u7f8e\u65cf\u4eba\u4ea4\u5f80\uff0c\u6700\u7ec8\u9009\u62e9\u7ad9\u5728\u539f\u4f4f\u6c11\u4e00\u8fb9\u53cd\u6297\u4eba\u7c7b\u7684\u6545\u4e8b &#8230;  <span class=\"dl\">\u70b9\u51fb\u67e5\u770b\u4e0b\u8f7d\u5730\u5740 &raquo;<\/span><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[],"class_list":["post-111","post","type-post","status-publish","format-standard","hentry","category-kehuan"],"_links":{"self":[{"href":"https:\/\/aclpharma.net\/index.php?rest_route=\/wp\/v2\/posts\/111","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/aclpharma.net\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/aclpharma.net\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/aclpharma.net\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/aclpharma.net\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=111"}],"version-history":[{"count":1,"href":"https:\/\/aclpharma.net\/index.php?rest_route=\/wp\/v2\/posts\/111\/revisions"}],"predecessor-version":[{"id":112,"href":"https:\/\/aclpharma.net\/index.php?rest_route=\/wp\/v2\/posts\/111\/revisions\/112"}],"wp:attachment":[{"href":"https:\/\/aclpharma.net\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=111"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/aclpharma.net\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=111"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/aclpharma.net\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=111"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}